You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,265,720


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,265,720 protect, and when does it expire?

Patent 9,265,720 protects EDLUAR and is included in one NDA.

This patent has twenty patent family members in twelve countries.

Summary for Patent: 9,265,720
Title:Pharmaceutical formulations useful in the treatment of insomnia
Abstract: There is provided a formulation suitable for transmucosal administration comprising a short acting hypnotic drug, which formulation provides a measurable plasma concentration of drug within 10 minutes of administration. The formulation is capable of providing sleep on demand, and preferably comprises particles of drug, for example zolpidem or a pharmaceutically-acceptable salt thereof and a mucoadhesion promoting agent, such as sodium carboxymethylcellulose, which particles of drug and mucoadhesive are presented upon the surface of larger carrier particles.
Inventor(s): Pettersson; Anders (Kode, SE), Nystrom; Christer (Stockholm, SE), Bredenberg; Susanne (Uppsala, SE)
Assignee: Orexo AB (Uppsala, SE)
Application Number:11/666,361
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with exclusive rights to their inventions. To navigate the complex landscape of US patents, it is essential to understand the scope and claims of a patent, as well as the broader patent landscape. This article will delve into the specifics of US Patent 9,265,720, and provide a comprehensive overview of the patent system in the United States.

What is a US Patent?

A US patent is a grant of exclusive rights to an inventor for their invention, issued by the United States Patent and Trademark Office (USPTO). The most common type of patent is the utility patent, which has a duration of 20 years from the date of filing but is not enforceable until the day of issuance[4].

The Patent Application Process

To obtain a patent, an applicant must submit a patent application to the USPTO. This application is reviewed by an examiner to determine if the invention is patentable. The process involves several stages, including filing, examination, and potentially, appeals and continuations[1].

Patent Claims

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. Claims must be clear, concise, and supported by the description in the patent specification. The USPTO provides detailed datasets on patent claims, which include information on claim-level statistics and document-level statistics, helping to understand the scope and complexity of patents[3].

Understanding the Scope of Patent 9,265,720

Patent Overview

US Patent 9,265,720, while not specifically detailed in the provided sources, can be analyzed using general principles of patent law and the structure of patent documents.

Claim Construction

Claim construction is a critical step in understanding the scope of a patent. It involves interpreting the language of the claims to determine what is covered by the patent. This process is a question of law and is reviewed de novo on appeal. Claims must be constructed to inform a person skilled in the field with reasonable certainty what is covered by the patent[2].

Claim Types

Patents typically include various types of claims, such as independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The construction of these claims must be consistent across all asserted patents[2].

Patent Landscape and Trends

Approval Rates

The probability of receiving a US patent varies significantly. Studies have shown that only about 55.8% of utility patent applications filed between 1996 and 2013 were eventually granted without using continuation procedures. The allowance rate has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications"[1].

Technology Fields

Patent applications are categorized into broad technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous "Other" category. Understanding these fields helps in analyzing the competitive landscape and the likelihood of patent approval[1].

Small Entities vs. Large Entities

The size of the entity filing the patent application can also impact the process. Small entities, defined as those with 500 or fewer employees, qualify for reduced fees and may face different challenges compared to large entities[1].

Challenges and Controversies

Patent Validity and Infringement

Patents are accompanied by a presumption of validity, but this does not mean they are immune to challenges. Inter partes review (IPR) and other post-grant proceedings can be used to challenge the validity of patents. The construction of claims and the determination of patentability are critical in these proceedings[2].

Need for a Small Claims Patent Court

There has been discussion about the need for a small claims patent court to address the high costs and complexity of patent litigation. The Administrative Conference of the United States (ACUS) has conducted studies on this topic, engaging with various stakeholders to explore the feasibility and structure of such a court[5].

Key Takeaways

  • Patent Claims: Clear and concise claims are essential for defining the scope of an invention.
  • Claim Construction: This is a legal process that determines the meaning of claim terms.
  • Patent Approval Rates: The likelihood of receiving a patent varies by technology field and has decreased over time.
  • Entity Size: Small entities face different challenges and benefits compared to large entities.
  • Patent Validity: Patents are presumed valid but can be challenged through various proceedings.
  • Small Claims Court: There is ongoing discussion about establishing a small claims patent court to address litigation costs.

FAQs

What is the typical duration of a US utility patent?

A US utility patent has a duration of 20 years from the date of filing but is not enforceable until the day of issuance[4].

How are patent claims constructed?

Claim construction involves interpreting the language of the claims to determine what is covered by the patent. This process is a question of law and is reviewed de novo on appeal[2].

What percentage of patent applications are typically granted?

Only about 55.8% of utility patent applications filed between 1996 and 2013 were eventually granted without using continuation procedures[1].

Why is there a discussion about a small claims patent court?

The discussion is driven by the high costs and complexity of patent litigation, with the aim of providing a more accessible and cost-effective forum for smaller entities[5].

What are the main types of patents in the US?

The main types include utility patents, design patents, and plant patents. Utility patents are the most common and protect functional inventions[4].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC. (2024). Retrieved from https://cafc.uscourts.gov/opinions-orders/24-1398.OPINION.9-16-2024_2384927.pdf
  3. USPTO. (2017). Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. BitLaw. Patent Law in the United States. Retrieved from https://www.bitlaw.com/patent/index.html
  5. ACUS. U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,265,720

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Speciality Lp EDLUAR zolpidem tartrate TABLET;SUBLINGUAL 021997-001 Mar 13, 2009 AB RX Yes No 9,265,720 ⤷  Subscribe METHOD OF TREATING INSOMNIA CHARACTERIZED BY DIFFICULTY WITH SLEEP ONSET ⤷  Subscribe
Mylan Speciality Lp EDLUAR zolpidem tartrate TABLET;SUBLINGUAL 021997-002 Mar 13, 2009 AB RX Yes Yes 9,265,720 ⤷  Subscribe METHOD OF TREATING INSOMNIA CHARACTERIZED BY DIFFICULTY WITH SLEEP ONSET ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,265,720

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0423800.2Oct 27, 2004
PCT Information
PCT FiledOctober 26, 2005PCT Application Number:PCT/GB2005/004147
PCT Publication Date:May 04, 2006PCT Publication Number: WO2006/046041

International Family Members for US Patent 9,265,720

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus 1118414 ⤷  Subscribe
Cyprus 1119580 ⤷  Subscribe
Denmark 1807156 ⤷  Subscribe
Denmark 2340872 ⤷  Subscribe
European Patent Office 1807156 ⤷  Subscribe
European Patent Office 2340872 ⤷  Subscribe
Spain 2610469 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.